Genelux (GNLX) Change in Accured Expenses (2022 - 2026)

Genelux's Change in Accured Expenses history runs 5 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 55.37% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at -$594000.0 (down 117.05% YoY), while the FY2025 annual figure was -$1.2 million, down 156.26% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $1.7 million, up from $374000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.8 million in Q4 2024, with the low at -$2.0 million in Q3 2025.
• The 5-year median for Change in Accured Expenses is $60000.0 (2022), against an average of $196357.1.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses tumbled 2909.09% in 2024, then jumped 634.93% in 2025.
• Genelux's Change in Accured Expenses stood at -$95000.0 in 2022, then jumped by 76.84% to -$22000.0 in 2023, then jumped by 8354.55% to $1.8 million in 2024, then slumped by 79.41% to $374000.0 in 2025, then soared by 364.44% to $1.7 million in 2026.
• Business Quant data shows GNLX's Change in Accured Expenses at $1.7 million in Q1 2026, $374000.0 in Q4 2025, and -$2.0 million in Q3 2025.